These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states. Pecori Giraldi F; Pivonello R; Ambrogio AG; De Martino MC; De Martin M; Scacchi M; Colao A; Toja PM; Lombardi G; Cavagnini F Clin Endocrinol (Oxf); 2007 Feb; 66(2):251-7. PubMed ID: 17223996 [TBL] [Abstract][Full Text] [Related]
3. In what clinical settings should Cushing's syndrome be suspected? Bruno OD; Juárez-Allen L; Rossi MA; Longobardi V Medicina (B Aires); 2009; 69(6):674-80. PubMed ID: 20053613 [TBL] [Abstract][Full Text] [Related]
4. Nocturnal 8 mg dexamethasone suppression test: a practical and accurate test for identification of the cause of endogenous Cushing's syndrome. Sriussadaporn S; Ploybutr S; Peerapatdit T; Plengvidhya N; Nitiyanant W; Vannasaeng S; Vichayanrat A Br J Clin Pract; 1996; 50(1):9-13. PubMed ID: 8729595 [TBL] [Abstract][Full Text] [Related]
5. Overnight dexamethasone suppression test: a reliable screen for Cushing's syndrome in the obese. Ness-Abramof R; Nabriski D; Apovian CM; Niven M; Weiss E; Shapiro MS; Shenkman L Obes Res; 2002 Dec; 10(12):1217-21. PubMed ID: 12490665 [TBL] [Abstract][Full Text] [Related]
6. Inferior petrosal sinus sampling in the diagnostic evaluation of Cushing's syndrome: K.E.M. experience. Kalgikar AM; Chandratreya SA; Goel A; Shrivastava M; Limaye US; Karvat A; Shah NS; Menon PS J Assoc Physicians India; 2005 Aug; 53():685-8. PubMed ID: 16398076 [TBL] [Abstract][Full Text] [Related]
7. The use of CRF-41 in the differential diagnosis of Cushing's syndrome and obesity. Grossman A; Howlett TA; Kopelman PG Horm Metab Res Suppl; 1987; 16():62-4. PubMed ID: 2832293 [TBL] [Abstract][Full Text] [Related]
8. [Investigation of Cushing's syndrome. The diagnostic value of the dexamethasone suppression test, the metopirone test and the CRF test]. Johannesen O; Jørgensen H; Frey H; Norman N Tidsskr Nor Laegeforen; 1989 Sep; 109(26):2678-82. PubMed ID: 2554527 [TBL] [Abstract][Full Text] [Related]
9. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome. Castro M; Elias LL; Elias PC; Moreira AC Clin Endocrinol (Oxf); 2003 Dec; 59(6):800-5. PubMed ID: 14974925 [TBL] [Abstract][Full Text] [Related]
10. [Simple obesity or cushing's syndrome? On the significance of the single dose dexamethasone suppression test in childhood]. Zurbrügg RP Ther Umsch; 1972 Sep; 29(9):530-4. PubMed ID: 5086405 [No Abstract] [Full Text] [Related]
11. Cushing's syndrome in women with polycystic ovaries and hyperandrogenism. Fegan PG; Sandeman DD; Krone N; Bosman D; Wood PJ; Stewart PM; Hanley NA Nat Clin Pract Endocrinol Metab; 2007 Nov; 3(11):778-83. PubMed ID: 17955019 [TBL] [Abstract][Full Text] [Related]
12. Evaluation and treatment of Cushing's syndrome. Nieman LK; Ilias I Am J Med; 2005 Dec; 118(12):1340-6. PubMed ID: 16378774 [TBL] [Abstract][Full Text] [Related]
13. An update on the overnight dexamethasone suppression test for the diagnosis of Cushing's syndrome: limitations in patients with mild and/or episodic hypercortisolism. Friedman TC Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):356-60. PubMed ID: 16915537 [TBL] [Abstract][Full Text] [Related]
14. A case of bronchial carcinoid tumor presenting clinical picture of Cushing's syndrome. Matsukage H; Hayashi H; Watanabe K; Takezawa H Mie Med J; 1970 Jan; 19(3):199-208. PubMed ID: 4321729 [No Abstract] [Full Text] [Related]
15. [Differential diagnosis of essential obesity and Cushing's syndrome]. Meng W Z Gesamte Inn Med; 1975 Dec; 30(24):796-8. PubMed ID: 1221658 [TBL] [Abstract][Full Text] [Related]